Literature DB >> 22754672

Successful treatment of gefitinib-induced acute interstitial pneumonitis with corticosteroid and non-invasive BIPAP-ventilation.

Yalei Zhang1, Haihong Yang, Meiling Zhao, Jianxing He.   

Abstract

This is the case of a 63 year-old male who was diagnosed adenocarcinoma in the left upper lung with ipsilateral malignant pleural effusion. At diagnosis it had already spread to left pulmonary HLN (hilar lymph node) and left supraclavicular lymph node and mediastinal lymph nodes. The patient received combined chemotherapy with bevacizumab and GP (gemcitabine and carboplatin) for 6 courses. Disease progression on chest CT scan was recognized, daily treatment with oral gefitinib (250 mg/day) was commenced. One week later, he was admitted under the impression of gefitinib-related interstitial pneumonitis, gefitinib was discontinued immediately and methylprednisolone with BIPAP assisted ventilation were used. The patient was followed up for 2 months after the start of treatment with corticosteroids and BIPAP assisted ventilation and remained well.

Entities:  

Keywords:  Gefitinib; interstitial pneumonitis; non-invasive BIPAP-ventilation

Year:  2012        PMID: 22754672      PMCID: PMC3378190          DOI: 10.3978/j.issn.2072-1439.2012.03.20

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  16 in total

1.  Ventilatory and hemodynamic effects of continuous positive airway pressure in left heart failure.

Authors:  F Lenique; M Habis; F Lofaso; J L Dubois-Randé; A Harf; L Brochard
Journal:  Am J Respir Crit Care Med       Date:  1997-02       Impact factor: 21.405

2.  Dose-related protection from nickel-induced lung injury in transgenic mice expressing human transforming growth factor-alpha.

Authors:  William D Hardie; Daniel R Prows; Alyssa Piljan-Gentle; Michelle R Dunlavy; Scott C Wesselkamper; George D Leikauf; Thomas R Korfhagen
Journal:  Am J Respir Cell Mol Biol       Date:  2002-04       Impact factor: 6.914

Review 3.  Non-invasive ventilation in acute cardiogenic pulmonary oedema.

Authors:  R Agarwal; A N Aggarwal; D Gupta; S K Jindal
Journal:  Postgrad Med J       Date:  2005-10       Impact factor: 2.401

Review 4.  Interstitial lung disease in lung cancer: separating disease progression from treatment effects.

Authors:  Sarah Danson; Fiona Blackhall; Paul Hulse; Malcolm Ranson
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

5.  Severe acute interstitial pneumonia and gefitinib.

Authors:  Akira Inoue; Yasuo Saijo; Makoto Maemondo; Kazunori Gomi; Yutaka Tokue; Yuichiro Kimura; Masahito Ebina; Toshiaki Kikuchi; Takuya Moriya; Toshihiro Nukiwa
Journal:  Lancet       Date:  2003-01-11       Impact factor: 79.321

Review 6.  Successful treatment of gefitinib-induced acute interstitial pneumonitis with high-dose corticosteroid: a case report and literature review.

Authors:  Li-Chiao Kuo; Po-Chou Lin; Ko-Fan Wang; Mei-Kang Yuan; Shih-Chieh Chang
Journal:  Med Oncol       Date:  2010-01-20       Impact factor: 3.064

7.  Elevated transforming growth factor-alpha levels in bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome.

Authors:  D K Madtes; G Rubenfeld; L D Klima; J A Milberg; K P Steinberg; T R Martin; G Raghu; L D Hudson; J G Clark
Journal:  Am J Respir Crit Care Med       Date:  1998-08       Impact factor: 21.405

8.  Cancer statistics, 2008.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2008-02-20       Impact factor: 508.702

Review 9.  Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease.

Authors:  F S F Ram; J Picot; J Lightowler; J A Wedzicha
Journal:  Cochrane Database Syst Rev       Date:  2004

10.  Expression of transforming growth factor-alpha and epidermal growth factor receptor is increased following bleomycin-induced lung injury in rats.

Authors:  D K Madtes; H K Busby; T P Strandjord; J G Clark
Journal:  Am J Respir Cell Mol Biol       Date:  1994-11       Impact factor: 6.914

View more
  3 in total

1.  Afatinib-Induced Acute Fatal Pneumonitis in Metastatic Lung Adenocarcinoma.

Authors:  Sang Hoon Yoo; Jin Ah Ryu; Seo Ree Kim; Su Yun Oh; Gu Sung Jung; Dong Jae Lee; Bong Gyu Kwak; Yu Hyun Nam; Kyung Hyun Kim; Young Jun Yang
Journal:  Korean J Fam Med       Date:  2016-11-18

2.  Gefitinib initiates sterile inflammation by promoting IL-1β and HMGB1 release via two distinct mechanisms.

Authors:  Takuya Noguchi; Yuto Sekiguchi; Yuki Kudoh; Rio Naganuma; Tomohiro Kagi; Akiko Nishidate; Kazuhiro Maeda; Chizuru Ishii; Takashi Toyama; Yusuke Hirata; Gi-Wook Hwang; Atsushi Matsuzawa
Journal:  Cell Death Dis       Date:  2021-01-06       Impact factor: 8.469

3.  Gefitinib-induced interstitial pneumonia: A case report and review of the literature.

Authors:  Changqin Luo; Meiling Lv; Yuyao Li; Peijun Liu; Jin Yang
Journal:  Exp Ther Med       Date:  2014-01-21       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.